30.500
+0.250
+(0.83%)
At close: 4:08:01 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
609,516
345,182
1,031,041
4,299,702
18,544
Cost of Revenue
521,897
1,221,201
1,217,648
1,297,769
13,804
Gross Profit
87,619
-876,019
-186,607
3,001,933
4,740
Operating Expense
957,378
1,202,887
1,261,962
1,201,354
445,063
Operating Income
-869,759
-2,078,906
-1,448,569
1,800,579
-440,323
Net Non Operating Interest Income Expense
19,409
35,714
24,098
58,957
31,581
Pretax Income
-924,745
-1,978,884
-1,184,001
1,936,787
-396,638
Tax Provision
-9,323
-11,451
-219,244
29,701
--
Net Income Common Stockholders
-866,676
-1,482,732
-909,431
1,914,390
-396,638
Diluted NI Available to Com Stockholders
-866,676
-1,482,732
-909,431
1,914,390
-396,638
Basic EPS
-3.51
-6.01
-3.68
7.74
-1.72
Diluted EPS
-3.51
-6.01
-3.68
7.74
-1.72
Basic Average Shares
246,783.500
246,766
247,022
247,450
230,917
Diluted Average Shares
247,449.899
246,766
247,022
247,450
230,917
Total Operating Income as Reported
-943,216
-2,035,182
-1,368,742
1,911,612
-400,859
Total Expenses
1,479,275
2,424,088
2,479,610
2,499,123
458,867
Net Income from Continuing & Discontinued Operation
-866,676
-1,482,732
-909,431
1,914,390
-396,638
Normalized Income
-808,592.544
-1,525,326.091
-976,954.155
1,845,421.123
-434,786
Interest Income
87,178
100,057
65,928
79,651
31,721
Interest Expense
67,593
64,145
41,341
20,419
--
Net Interest Income
19,409
35,714
24,098
58,957
31,581
EBIT
-857,152
-1,914,739
-1,142,660
1,957,206
-396,638
EBITDA
-857,152
-1,645,686
-946,300
2,045,748
-364,821
Reconciled Cost of Revenue
521,897
1,221,201
1,217,648
1,297,769
13,804
Reconciled Depreciation
--
269,053
196,360
88,542
31,817
Net Income from Continuing Operation Net Minority Interest
-866,676
-1,482,732
-909,431
1,914,390
-396,638
Total Unusual Items Excluding Goodwill
-58,675
42,842
82,868
70,043
38,148
Total Unusual Items
-58,675
42,842
82,868
70,043
38,148
Normalized EBITDA
-798,477
-1,688,528
-1,029,168
1,975,705
-402,969
Tax Rate for Calcs
0
0
0
0
--
Tax Effect of Unusual Items
-591.544
247.909
15,344.845
1,074.123
--
12/31/2020 - 3/28/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2196.HK Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
14.260
+1.13%
3839.HK Chia Tai Enterprises International Limited
1.700
+10.39%
0897.HK WAI YUEN TONG
0.320
-5.88%
3320.HK China Resources Pharmaceutical Group Limited
4.960
-1.20%
2186.HK Luye Pharma Group Ltd.
1.860
-1.06%
1558.HK HEC CJ PHARM
11.500
0.00%
3692.HK Hansoh Pharmaceutical Group Company Limited
22.150
-2.85%
0460.HK SIHUAN PHARM
0.640
+1.59%
1681.HK CONSUN PHARMA
9.630
-1.33%
0013.HK HUTCHMED
22.550
-1.96%